Category: UK

STAT+: U.K. is urged to probe drugmakers for conspiring to scrap or halt investments amid pricing disputes The U.K.’s antitrust regulator has been asked by patient advocacy groups to investigate several large drugmakers and their U.K. lobbying organization for “suspected” and “coordinated” efforts to drive up the prices of medicines. The backdrop to the complaint…